In breast cancer cells, MMP-14 modulates DNA damage response through extracellular integrinβ1 signaling[19], whereas MMP-14 knockdown in ACC cells did not affect integrinβ1 downstream targets, as evidenced by unchanged AKT and ERK phosphorylation. The gene discussed is AKT1; the disease is adrenal cortex carcinoma.